Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity
JCI Insight · 22.05.2026 · 11 (10)
DOI: 10.1172/jci.insight.205174 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 31.03.2026. Verfasst von Anna J Son und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Adiposity, Obesity, Drug Resistance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RRD VA, NIAMS NIH HHS, NIAMS.
Abstract (Originalsprache)
Stopping and restarting GLP-1 weight-loss drugs in mice made them less effective over time and increased fat gain compared with continuous treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
- Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
Förderung
- RRD VA
- NIAMS NIH HHS
- NIAMS
- VA
- NIH
- Berstein Foundation
- H.T. Leung Foundation
Zitieren
APA
Son, A. J., Rapp, E., Wiezorek, A., Leung, M. G., Banerjee, R. R., & Leung, T. H. (2026). Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. JCI Insight, 11(10). https://doi.org/10.1172/jci.insight.205174
Vancouver
Son AJ, Rapp E, Wiezorek A, Leung MG, Banerjee RR, Leung TH. Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. JCI Insight. 2026;11(10). doi:10.1172/jci.insight.205174
BibTeX
@article{Son2026,
author = {Son, Anna J and Rapp, Emmanuel and Wiezorek, Alex and Leung, Max G and Banerjee, Ronadip R and Leung, Thomas H},
title = {Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {10},
doi = {10.1172/jci.insight.205174}
}
EUVIMED